The impact of inherited thrombophilia on first trimester combined aneuploidy screening test parameters

References

• Wright D, Spencer K, Nix B. First trimester screening for Down syndrome using free beta hCG, total hCG and PAPP-A: an exploratory study. Prenat Diagn. 2007;27:1118–22
   PubMed Web of Science ®Google Scholar
• Jaques AM, Halliday JL, Francis I, et al. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18. BJOG 2007;114:812–8
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Spencer CE, Achillea N. A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn 2010;30:937–40
   PubMed Web of Science ®Google Scholar
• Spencer K, Staboulidou I, Nicolaides KH. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers. Prenat Diagn 2010;30:235–40
   PubMed Web of Science ®Google Scholar
• Cowans NJ, Stamatopoulou A, Spencer K. The effect of Rhesus status on first-trimester pregnancy screening markers free beta human chorionic gonadotropin, pregnancy-associated plasma protein-A and nuchal translucency. Prenat Diagn 2009;29:505–7
   PubMed Web of Science ®Google Scholar
• Muhcu M, Mungen E, Atay V, et al. First trimester screening for Down syndrome in rhesus negative women. Prenat Diagn. 2008;28:404–7
   Google Scholar
• Spencer K, Cicero S, Atzei A, et al. The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn 2005;25:927–9
   PubMed Web of Science ®Google Scholar
• Spencer K, Heath V, El-Sheikhah A, et al. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn. 2005;25:365–9
   PubMed Web of Science ®Google Scholar
• Barrett SL, Bower C, Hadlow NC. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Prenat Diagn 2008;28:28–35
   PubMed Web of Science ®Google Scholar
• Smith GC, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002;87:1762–7
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 2008;28:7–10
   PubMed Web of Science ®Google Scholar
• Yaron Y, Heifetz S, Ochshorn Y, et al. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002;22:778–82
   PubMed Web of Science ®Google Scholar
• Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001–11
   PubMed Web of Science ®Google Scholar
• James DK, Steer PJ, Weiner CP, Gonik B. High risk pregnancy. Philadelphia: Saunders, 1995; pp. 614–15
   Google Scholar
• Goetzinger KR, Cahill AG, Macones GA, Odibo AO. Association of first-trimester low PAPP-A levels with preterm birth. Prenat Diagn 2010;30:309–13
   PubMed Web of Science ®Google Scholar
• Coskun A, Balbay O, Duran S, et al. Pregnancy-associated plasma protein-A and asthma. Adv Ther 2007;24:362–7
   PubMed Web of Science ®Google Scholar
• Laterza OF, Cameron SJ, Chappell D, et al. Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clin Chim Acta 2004;348:163–9
   PubMed Web of Science ®Google Scholar
• Coppens M, Folkeringa N, Teune MJ, et al. Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations. J Thromb Haemost 2007;5:1444–8
   PubMed Web of Science ®Google Scholar
• Grandone E, Brancaccio V, Colaizzo D, et al. Preventing adverse obstetric outcomes in women with genetic thrombophilia. Fertil Steril 2002;78:371–5
   PubMed Web of Science ®Google Scholar
• Hills FA, Abrahams VM, Gonzalez-Timon B, et al. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 2006;12:37–43
   Google Scholar
• Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688–98
   PubMed Web of Science ®Google Scholar
• Conover CA, Harrington SC, Bale LK. Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. Growth Horm IGF Res 2008;18:213–20
   Google Scholar
• Wittfooth S, Tertti R, Lepantalo M, et al. Studies on the effects of heparin products on pregnancy-associated plasma protein A. Clin Chim Acta 2011;412:376–81
   Google Scholar
• Spencer K, Enofe O, Cowans NJ, Stamatopoulou A. Is maternal renal disease a cause of elevated free beta-hCG in first trimester aneuploidy screening? Prenat Diagn 2009;29:1045–9
   Google Scholar
• Ardawi MS, Nasrat HA, Rouzi AA, et al. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Prenat Diagn 2007;27:303–11
   PubMed Web of Science ®Google Scholar
• Yaron Y, Ochshorn Y, Tsabari S, Shira AB. First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin. Prenat Diagn 2004;24:445–50
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992;304:867–9
   PubMed Web of Science ®Google Scholar
• Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352:343–6
   PubMed Web of Science ®Google Scholar
• Derbent AU, Yanik FF, Inegol Gumus I, et al. Impact of inherited thrombophilias on first and second trimester maternal serum markers for aneuploidy. J Matern Fetal Neonatal Med 2012;25:2177–81
   PubMed Web of Science ®Google Scholar
• Tarim E, Cok T, Hacivelioglu S, Bagis T. Low molecular weight heparin and first trimester maternal PAPP-A and hCG levels, fetal nuchal translucency in the first trimester of pregnancy. Clin Exp Obstet Gynecol 2011;38:81–3
   Google Scholar